CorneaGen raises $37M in Series B funding round

CorneaGen focuses on innovating technologies to cure corneal blindness by 2040 and provides donor tissues for cornea transplants.

Previous Bardavon CEO Condon: New partnership accelerates 'rocket ship of growth'
This is the most recent story.

No Comment

Leave a reply

Your email address will not be published. Required fields are marked *